200 related articles for article (PubMed ID: 25668433)
41. Mammalian Target of Rapamycin Inhibition in
Rojas Márquez JD; Ana Y; Baigorrí RE; Stempin CC; Cerban FM
Front Immunol; 2018; 9():313. PubMed ID: 29515594
[TBL] [Abstract][Full Text] [Related]
42. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
43. High fat diet modulates inflammatory parameters in the heart and liver during acute Trypanosoma cruzi infection.
Figueiredo VP; Junior ESL; Lopes LR; Simões NF; Penitente AR; Bearzoti E; Vieira PMA; Schulz R; Talvani A
Int Immunopharmacol; 2018 Nov; 64():192-200. PubMed ID: 30195817
[TBL] [Abstract][Full Text] [Related]
44. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease.
Korish AA; Arafah MM
BMC Complement Altern Med; 2013 Oct; 13():264. PubMed ID: 24119413
[TBL] [Abstract][Full Text] [Related]
45. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T; Kumar N; Perriotte-Olson C; Casey CA; Donohue TM; Harris EN; Talmon G; Kabanov AV; Saraswathi V
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G428-G438. PubMed ID: 31928222
[TBL] [Abstract][Full Text] [Related]
46. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
47. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
Ye D; Yang K; Zang S; Lin Z; Chau HT; Wang Y; Zhang J; Shi J; Xu A; Lin S; Wang Y
J Hepatol; 2016 Nov; 65(5):988-997. PubMed ID: 27266617
[TBL] [Abstract][Full Text] [Related]
48. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis.
Tomita K; Freeman BL; Bronk SF; LeBrasseur NK; White TA; Hirsova P; Ibrahim SH
Sci Rep; 2016 Jun; 6():28786. PubMed ID: 27349927
[TBL] [Abstract][Full Text] [Related]
49. A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.
Moro T; Nakao S; Sumiyoshi H; Ishii T; Miyazawa M; Ishii N; Sato T; Iida Y; Okada Y; Tanaka M; Hayashi H; Ueha S; Matsushima K; Inagaki Y
PLoS One; 2016; 11(1):e0146592. PubMed ID: 26745268
[TBL] [Abstract][Full Text] [Related]
50. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
51. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
[TBL] [Abstract][Full Text] [Related]
52. Metabolic syndrome agravates cardiovascular, oxidative and inflammatory dysfunction during the acute phase of Trypanosoma cruzi infection in mice.
Lucchetti BFC; Boaretto N; Lopes FNC; Malvezi AD; Lovo-Martins MI; Tatakihara VLH; Fattori V; Pereira RS; Verri WA; de Almeida Araujo EJ; Pinge-Filho P; Martins-Pinge MC
Sci Rep; 2019 Dec; 9(1):18885. PubMed ID: 31827186
[TBL] [Abstract][Full Text] [Related]
53. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
Lambertucci F; Arboatti A; Sedlmeier MG; Motiño O; Alvarez ML; Ceballos MP; Villar SR; Roggero E; Monti JA; Pisani G; Quiroga AD; Martín-Sanz P; Carnovale CE; Francés DE; Ronco MT
J Nutr Biochem; 2018 Aug; 58():17-27. PubMed ID: 29860102
[TBL] [Abstract][Full Text] [Related]
54. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
[TBL] [Abstract][Full Text] [Related]
55. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
Front Immunol; 2020; 11():306. PubMed ID: 32194558
[TBL] [Abstract][Full Text] [Related]
56. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
[TBL] [Abstract][Full Text] [Related]
57. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
58. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
[TBL] [Abstract][Full Text] [Related]
59. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability.
Li J; Sapper TN; Mah E; Moller MV; Kim JB; Chitchumroonchokchai C; McDonald JD; Bruno RS
J Nutr Biochem; 2017 Mar; 41():34-41. PubMed ID: 28038359
[TBL] [Abstract][Full Text] [Related]
60. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
